Penserra Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,095
Closed -$25K 562
2017
Q1
$25K Buy
4,095
+1,755
+75% +$10.7K ﹤0.01% 374
2016
Q4
$14K Sell
2,340
-200
-8% -$1.2K ﹤0.01% 736
2016
Q3
$18K Buy
2,540
+635
+33% +$4.5K ﹤0.01% 579
2016
Q2
$16K Buy
1,905
+164
+9% +$1.38K ﹤0.01% 501
2016
Q1
$11 Buy
1,741
+549
+46% +$3 ﹤0.01% 508
2015
Q4
$10K Buy
+1,192
New +$10K ﹤0.01% 521